We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Beta measures a stock's volatility in comparison to the overall market. By definition, the market, such as the S&P 500 Index, has a beta of 1.0.
A beta above 1.0 suggests a stock is more volatile than the broader market, and a beta below 1.0 indicates the opposite. Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities.
They can also offer stabilization when combined with high-beta stocks, helping to give a more balanced risk profile.
Three low-beta stocks – Interactive Brokers (IBKR - Free Report) , Elevance Health (ELV - Free Report) , and Consolidated Edison (ED - Free Report) – could all be considered for those looking for a more conservative approach.
In addition to decreased volatility, all three sport a favorable Zacks Rank, reflecting optimism among analysts.
Let’s take a closer look at each.
Elevance Health Keeps Beating Earnings Expectations
Elevance Health operates as a health benefits company, supporting consumers, families, and communities throughout the care journey to lead healthier lives. The company sports a favorable Zacks Rank #2 (Buy), with earnings expectations inching higher nearly across the board.
ELV’s latest quarterly results pleased investors, with shares moving well higher after the earnings release. Regarding headline figures, Elevance posted a 1% beat relative to the Zacks Consensus EPS estimate and reported sales modestly below expectations.
Earnings grew 12.5% year over year, whereas sales increased 1%. Below is a chart illustrating the company’s quarterly revenue.
Image Source: Zacks Investment Research
Interactive Brokers Crushes S&P 500
Interactive Brokers Group operates as an automated global electronic market maker and broker. Analysts have positively revised expectations across the board, landing the stock into a favorable Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
It’s worth noting that the stock is a big-time outperformer over the last two years, adding an impressive 125% in value compared to the S&P 500’s 50% gain. Increased trading activity has benefited the company nicely over recent years.
Image Source: Zacks Investment Research
Consolidated Edison Keeps Rewarding Shareholders
Consolidated Edison, a current Zacks Rank #2 (Buy), is a diversified utility holding company with subsidiaries engaged in both regulated and unregulated businesses. The company has been a great earnings performer, exceeding the Zacks Consensus EPS estimate by an average of 6% across its last four releases.
Income-focused investors could find ED shares attractive, currently yielding a solid 3.8% annually. Dividend growth is also apparent, with the company sporting a modest 2% five-year annualized dividend growth rate.
The company has long displayed a shareholder-friendly nature, as we can see illustrated below.
Image Source: Zacks Investment Research
Bottom Line
Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities.
They can also offer stabilization when combined with high-beta stocks, helping to give a more balanced risk profile.
And for those seeking a more conservative approach, all three low-beta stocks above - Interactive Brokers (IBKR - Free Report) , Elevance Health (ELV - Free Report) , and Consolidated Edison (ED - Free Report) – could be considerations.
In addition to decreased volatility, all three sport favorable Zacks Ranks, reflecting optimism among analysts.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tame Volatility with These 3 Low Beta Stocks
Beta measures a stock's volatility in comparison to the overall market. By definition, the market, such as the S&P 500 Index, has a beta of 1.0.
A beta above 1.0 suggests a stock is more volatile than the broader market, and a beta below 1.0 indicates the opposite. Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities.
They can also offer stabilization when combined with high-beta stocks, helping to give a more balanced risk profile.
Three low-beta stocks – Interactive Brokers (IBKR - Free Report) , Elevance Health (ELV - Free Report) , and Consolidated Edison (ED - Free Report) – could all be considered for those looking for a more conservative approach.
In addition to decreased volatility, all three sport a favorable Zacks Rank, reflecting optimism among analysts.
Let’s take a closer look at each.
Elevance Health Keeps Beating Earnings Expectations
Elevance Health operates as a health benefits company, supporting consumers, families, and communities throughout the care journey to lead healthier lives. The company sports a favorable Zacks Rank #2 (Buy), with earnings expectations inching higher nearly across the board.
ELV’s latest quarterly results pleased investors, with shares moving well higher after the earnings release. Regarding headline figures, Elevance posted a 1% beat relative to the Zacks Consensus EPS estimate and reported sales modestly below expectations.
Earnings grew 12.5% year over year, whereas sales increased 1%. Below is a chart illustrating the company’s quarterly revenue.
Image Source: Zacks Investment Research
Interactive Brokers Crushes S&P 500
Interactive Brokers Group operates as an automated global electronic market maker and broker. Analysts have positively revised expectations across the board, landing the stock into a favorable Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
It’s worth noting that the stock is a big-time outperformer over the last two years, adding an impressive 125% in value compared to the S&P 500’s 50% gain. Increased trading activity has benefited the company nicely over recent years.
Image Source: Zacks Investment Research
Consolidated Edison Keeps Rewarding Shareholders
Consolidated Edison, a current Zacks Rank #2 (Buy), is a diversified utility holding company with subsidiaries engaged in both regulated and unregulated businesses. The company has been a great earnings performer, exceeding the Zacks Consensus EPS estimate by an average of 6% across its last four releases.
Income-focused investors could find ED shares attractive, currently yielding a solid 3.8% annually. Dividend growth is also apparent, with the company sporting a modest 2% five-year annualized dividend growth rate.
The company has long displayed a shareholder-friendly nature, as we can see illustrated below.
Image Source: Zacks Investment Research
Bottom Line
Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities.
They can also offer stabilization when combined with high-beta stocks, helping to give a more balanced risk profile.
And for those seeking a more conservative approach, all three low-beta stocks above - Interactive Brokers (IBKR - Free Report) , Elevance Health (ELV - Free Report) , and Consolidated Edison (ED - Free Report) – could be considerations.
In addition to decreased volatility, all three sport favorable Zacks Ranks, reflecting optimism among analysts.